CARE Ratings Ltd
CARE Ratings Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 investor presentation: what the company reported on revenue, margins and projects.
Based on CARE Ratings Ltd's Q2 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Q2 FY26 Standalone Revenue from Operations: Rs. Q2 FY26 Standalone Figures: - EBITDA: Rs.
From CARE Ratings Ltd's Q2 FY26 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
- Q2 FY26 Standalone Revenue from Operations: Rs. 114.27 crores, up 13% YoY
- Q2 FY26 Consolidated Revenue from Operations: Rs. 136.37 crores, up 16% YoY
- Q2 FY26 Standalone EBITDA: Rs. 64.97 crores, up 14% YoY; Margin: 57%
- Q2 FY26 Consolidated EBITDA: Rs. 68.41 crores, up 23% YoY; Margin: 50%
- Q2 FY26 Standalone PAT: Rs. 55.83 crores, up 12% YoY; Margin: 44%
- Q2 FY26 Consolidated PAT: Rs. 57.21 crores, up 22% YoY; Margin: 38%
- H1 FY26 Standalone Revenue: Rs. 189.91 crores, up 14% YoY
- H1 FY26 Consolidated Revenue: Rs. 230.28 crores, up 17% YoY
2 more points management made on revenue & sales performance
Profitability & Margins
See what CARE Ratings Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
Top-ranked in Capital Markets
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what CARE Ratings Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
CARE Ratings Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹131 Cr, net profit ₹53 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What CARE Ratings Ltd's management said in earlier quarters
- Q1 FY25 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q2 FY25 earnings call analysis →
- Q4 FY24 earnings call →
- Q4 FY23 earnings call →
- Q3 FY22 earnings call →
- Q2 FY22 earnings call →
- Q4 FY20 earnings call →
- Q2 FY20 earnings call →
- Q1 FY20 earnings call →
- Q4 FY19 earnings call →
Others in Capital Markets this season
- Dam Capital Advisors Ltd (Q2 FY26)
Total income for Q2 FY26: INR 107 Cr, up 69% YoY from INR 63 Cr in Q2 FY25 (Page 3). Key concall takeaways from Dam Capital Advisors Ltd's Q2 FY26 earnings…
- Nippon Life India Asset Management Ltd (Q2 FY26)
ETF segment poised for growth with a healthy 20% market share; further expansion possible as market grows, especially in gold and silver ETFs which show…
- Rikhav Securitie (Q2 FY26)
100 crores in the next 5 years. Key concall takeaways from Rikhav Securities Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.
- Indian Energy Exchange Ltd (Q2 FY26)
Electricity traded volumes grew by 16% in H1 FY '26 despite flat overall power demand, indicating strong market growth potential. Key concall takeaways from…
Frequently Asked Questions
What were CARE Ratings Ltd Q2 FY26 results?
Q2 FY26 Standalone Revenue from Operations: Rs. Q2 FY26 Standalone Figures: - EBITDA: Rs.
What is CARE Ratings Ltd share price analysis?
CARE Ratings Ltd currently shows a neutral. The stock trades at a P/E of 28.3 with a market cap of ₹5,026 Cr. Investors should review the full earnings analysis for detailed insights.
Is CARE Ratings Ltd planning capital expenditure?
The investor presentation does not mention any capex, capacity expansion, or new plant/project details including amounts, status, or timelines.
Keep CARE Ratings Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.